CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
TesioCath +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01022359
NCT01022359N/ACompleted
CompareCT.gov

Comparison of Tesio and LifeCath Twin Permanent Dialysis Catheters

Imperial College Healthcare NHS Trust·interventional·Posted Dec 1, 2009·Updated Apr 22, 2021

In Brief

A clinical study evaluating TesioCath and LifeCath Twin for Hemodialysis. Completed, enrolled 80 participants across 1 site.

Detailed Summary

This study aims to compare two available types of central venous haemodialysis catheters (lines) - CVCs, and will examine how easy they are to insert, complications, blood flow on dialysis over time, line loss, line clotting and infective events. It will examine whether the LifeCath type of CVC can deliver high blood flow rates from first use after insertion and equivalent function and complication rate to the Tesio type of CVC that is in use in our centre already. Complications relating to dialysis access make up 30% of admissions for haemodialysis patients and so this is a study that could benefit patients and their care providers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemodialysis
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 1, 2009
Enrollment StartOct 1, 2008
Primary CompletionJul 1, 2010
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.6 years ago

Interventions

TesioCathdevice

Insertion of the TesioCath(TM) central venous catheter for haemodialysis vascular access

LifeCath Twindevice

Insertion of the LifeCath Twin central venous catheter for haemodialysis vascular access